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Abstract
Developing technologies such as unnatural amino acid mutagenesis, non-natural cofactor
engineering, and computational design are generating proteins with novel functions; these
proteins, however, often do not reach performance targets and would benefit from further
optimization. Evolutionary methods can complement these approaches: recent work combining
unnatural amino acid mutagenesis and phage selection has created useful proteins of novel
composition. And weak initial activity in a computationally designed enzyme has been improved
by iterative rounds of mutagenesis and screening. A marriage of ingenuity and evolution will
expand the scope of protein function well beyond Mother Nature’s designs.
Introduction
Protein engineering has emerged as a powerful vehicle for the development of important
protein-based tools, including biocatalysts, biosensors, and therapeutics. The ability to tailor
proteins for a specific purpose is the ultimate test of our understanding of their structure and
function; it is unfortunately a test that is all too often failed. The complex and subtle
interplay of interactions that dictates fold and function presents a daunting obstacle to
rational protein design. Evolution is Nature’s solution to the design problem. Scientists have
learned how to implement evolutionary strategies to engineer new proteins, exploiting
natural protein scaffolds as starting points for breeding improved versions. A not-surprising
testament to the power of natural selection is that the most reliable approach to optimizing
protein function is by iterative rounds of mutagenesis and screening or selection, i.e.
directed evolution [1-3].
Protein engineers are rapidly moving beyond merely improving on natural proteins, which
carry out their biological functions with breath-taking efficiency but may not be suitable for
the myriad other applications on the protein chemist’s wish list. A general lesson that has
come out of laboratory evolution efforts is that it is easier to improve an existing, albeit low,
activity than it is to discover a new one. There is evidence that at least one mechanism by
which a novel enzyme evolves is from an existing ‘promiscuous’ activity, which is captured
and optimized (often after gene duplication) by natural selection [4]. Laboratory evolution
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experiments show that such side activities in fact can often be increased and optimized.
Generating a function where it does not already exist, not even at a low level, however, is a
bigger challenge that will benefit from the use of new technologies that improve the design
process or that provide new chemical functionalities not present in natural systems.
The past decade has demonstrated that synthetic and computational tools can be exploited to
generate proteins with novel structural and chemical properties. Protein sequence space is no
longer limited to the functionality presented by the canonical genetic code, as a wide variety
of unnatural amino acids (UAAs) can now be incorporated into proteins in vitro and in vivo
[5]. In addition, considerable work has been applied to engineer artificial metallocenters and
non-natural cofactors into proteins [6]. With this rapidly expanding chemical diversity
available for protein engineering, the functional space may be limited ultimately by the
imagination of the protein scientist. While these strategies provide the ability to add new
chemical functionality, overcoming certain limitations will be key to their wide use in
protein engineering. Unnatural amino acid technologies, for example, often suffer from
decreased protein yields due in part to decreased protein stability or inefficient translation,
and the introduction of new transition metals is often limited by cross-reactivity with other
components of the cellular milieu, necessitating extensive protein purification before the
metal can be introduced [6].
Computational approaches to protein design are also building on our growing understanding
of protein structure and function. Entire protein folds and proteins that catalyze reactions not
present in Nature have been designed in silico and constructed [7,8•,9,10••]. Nonetheless,
while considerable achievements have been made, the results are less impressive when they
are compared to the products of natural evolution. For example, the abilities of naturally
evolved enzymes can be appreciated by comparing the rate constant for the enzyme-
catalyzed reaction to that of the spontaneous uncatalyzed reaction (kcat/kuncat). Enzymes
demonstrate rate enhancements as high as 1019, and values of 1012 are not uncommon [11].
The best computationally designed enzymes, however, exhibit enhancements (<106) that are
many orders of magnitude lower.
Directed evolution complements these methods by (1) improving new protein designs
through mutation and selection, with the ultimate goal of providing molecules with useful
synthetic and therapeutic properties and by (2) demonstrating the limitations and drawbacks
of these methods, stimulating improvements into next generation protein designs. Here we
will highlight selected work demonstrating how these advances in biotechnology are
providing new opportunities for the directed evolution of non-natural protein functions.
Directed Evolution with Unnatural Amino Acids
The past twenty years have seen remarkable advances in methods for incorporating
unnatural amino acids (UAAs) into proteins. A variety of techniques have been developed,
including native protein ligation, global amino acid replacement, in vitro translation or direct
cellular injection of chemically aminoacylated tRNAs, and the generation of orthogonal
tRNA/aminoacyl-tRNA synthetase pairs for the site-specific incorporation of amino acids in
vivo. The foundations of this research have been thoroughly detailed elsewhere; we point the
reader to several excellent recent reviews [5,12,13].
For the most part, experiments involving the introduction of UAAs into proteins have
focused on new chemical diversity that yields a specific function, with little effort placed on
further tailoring the protein for that function. Nevertheless, the novel chemical functionality
has already been used in interesting applications. Some recent highlights include work by
Grunewald et al., who demonstrated that incorporation of an immunogenic p-
nitrophenylalanine residue into a protein could overcome self-tolerance in autologous host
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proteins, providing a new tool for immunotherapy [14•]. Injection of mice with a p-
nitrophenylalanine-modified mouse tumor necrosis factor (mTNF) led to the formation of
cross-reactive antibodies that recognized both the modified and wild type mTNF. Mills et al.
have shown that a genetically-encoded fluorescent coumarin amino acid can be introduced
into the antigen-binding region of a Fab specific for CD40 ligand [15]. Changes in
fluorescence can be used to monitor ligand binding, perhaps providing a general means for
genetically encoding antibody-based biosensors. Tirrell, Schuman and colleagues have
demonstrated that ‘click’ reactive azidohomoalanine and homopropargylglycine amino acids
can be introduced globally into proteins in living cells by exploiting the promiscuity of host
methionyl-tRNA synthetases. By combining pulse chase amino acid incorporation and
labeling with various ‘click’ reactive fluorophores, they were able to image newly
synthesized proteins at various time points in rat hippocampal neurons [16•]. In addition,
with a modified methionyl tRNA synthetase specific for longer ‘click’ amino acid
homologues, they were able to achieve cell-specific protein labeling in a mixed cell
population [17•].
Although introduction of UAAs provides new chemical functionality, it is also disruptive:
proteins containing UAAs often exhibit reduced native activity and lower stability. As
technologies for in vivo UAA incorporation advance, we can consider using directed
evolution to improve proteins containing UAAs. The first example of laboratory evolution
with UAAs was work performed by Wong [18] and later by Bacher and Ellington [19].
Using chemical mutagenesis or spontaneous mutation in cell culture, respectively, they
demonstrated that bacterial cells grown in the presence of a cytotoxic fluorinated tryptophan
homologue would, over generations, evolve tolerance to the new amino acid. As shown by
Bacher et al. [19], these cells were able to grow, albeit more slowly, with the fluorinated
homologue as their sole tryptophan source, suggesting almost complete proteomic
replacement of tryptophan. Overexpression of a model protein, glutathione S-transferase
(GST), in the evolved bacterial strain in the presence of the modified tryptophan yielded
only the fluorinated protein, as determined by mass spectrometry.
Tirrell and colleagues have performed similar experiments looking at global replacement of
an amino acid in individual proteins. Using a minimal growth medium supplemented with
5′,5′,5′-trifluoroleucine (TFL), they were able to completely replace the canonical leucine
with TFL in chloramphenicol acetyl transferase (CAT, 13 leucines) [20] and GFP (19
leucines) [21]. This came at significant cost, however, to protein function. They then asked
whether native activity could be restored by directed evolution. Global leucine replacement
in CAT resulted in a decrease in T50 (temperature at which half the native activity is lost
after 30 minute incubation) of 9°C. Three rounds of error-prone PCR random mutagenesis
and screening for improved retention of activity at high temperatures generated a CAT TFL
variant whose stability matched that of the wild type enzyme and whose kcat/Km was only
slightly decreased. Global incorporation of TFL in GFP led to protein misfolding and loss of
fluorescence. Eleven rounds of error-prone PCR and FACS screening for improved
fluorescence produced a GFP TFL mutant with fluorescence and folding properties similar
to wild type GFP. Of the 19 leucine residues in GFP, 6 were mutated to other canonical
amino acids, suggesting that there are specific locations at which TFL cannot be
accommodated. It is interesting to note that expressing the same variant with leucine rather
than TFL also improved folding and expression compared to wild type GFP. This suggests
that the directed evolution experiments increased overall protein stability, which permits
UAA incorporation.
It is particularly interesting to generate proteins with functions that are not available to or
surpass those of natural proteins. Exciting work by Liu, Schultz and colleagues has laid the
groundwork for the discovery and evolution of novel binding sequences containing UAAs
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using phage display. In this work, a pIII hyperphage phagemid expression system was
adapted for use in E. coli strains (X - E. coli) expressing orthogonal tRNA/aminoacyl-tRNA
synthetase pairs that were evolved for incorporation of UAAs into proteins in response to
the TAG stop codon (figure 1a) [22•]. Initial tests in a TAG-containing human-derived scFv
demonstrated that phage production depended on the presence of the UAA; however,
significant optimization was needed to limit expression bias due to inefficient incorporation
of the UAA.
To test unnatural amino acid selection, a known post-translationally modified sulfotyrosine
(sY)-containing antibody (412d) was examined (figure 1a - 1c) [22•,23••]. 412d is specific
for the HIV coat protein gp120, and sulfation of two tyrosine residues within 412d (412d-
sYsY, figure 1b) is required for antigen binding. Liu et al. recently reported the evolution of
an orthogonal tRNA synthetase capable of directly incorporating sY into proteins [24]. Four
rounds of phage selection against immobilized gp120 were performed using a doped library
containing low levels of 412d-sYsY (1/2000) in a library of 412d sequences randomized at
both sY positions and 4 other sites using a degenerate NNK codon (codes for 20 amino acids
and the TAG stop codon). Sequencing of clones after each round of selection showed
convergence to the wild type 412d sequence and new sequences also enriched in sY [22•].
Selection for tyrosine-containing 412d (412d-YY) yielded no such enrichment. In a follow-
up experiment, 412d libraries were constructed in which both sY residues were fixed using
UAA mutagenesis and nearby residues were randomized (figure 1b) [23••]. After 4 rounds
of selection a variety of new sequences were isolated showing divergence from the wild type
412d (figure 1b). These sequences would not be available in nature due to strict sequence
determinants for post-translation tyrosine sulfation. One isolated variant, 131-3, binds gp120
with an affinity (0.51 nM) similar to that of wild type 412d (0.63 nM). Kinetic analysis of
Fab binding demonstrated that improvements in kon over 412d were achievable; however, no
decrease in koff was observed (figure 1b). This inability to improve on the natural 412d
antibody might reflect a limitation of the selection: Fab-antigen complex half-lives for wild
type and evolved variants were determined to be at least 3 fold greater than the 30 minute
experimental washing procedure used during phage selection (figure 1a), suggesting that
longer washing steps may be required to select for tighter-binding antibody sequences
[23••].
Phage selection is of course not limited to mimicking naturally occurring post-translational
modifications. Selections were performed using a boronic acid-containing amino acid and a
human-derived germline scFv randomized at 6 positions within CDR3 [25•]. Boronic acids
demonstrate strong affinity for hydroxyl moieties, in particular 1,2-diols (figure 1d).
Selection against an immobilized polyhydroxylated resin provided sequences enriched for
boronic acids. The ability to select for sequences containing boronic acid UAAs may open
the door to generating therapeutic proteins containing ‘chemical warheads’ specific for
various biologically relevant sugars, or artificial lectins.
Limitations of site-specific UAA incorporation include limitations in the number of different
UAAs that can be incorporated at one time, reduced translational efficiency at TAG codons
and limited ribosomal incorporation of alternative amino acid structures (e.g. reduced
incorporation efficiency of C-alpha substituted- and D-amino acids). Many of these
limitations occur at the level of the ribosome. Chin and colleagues recently used directed
evolution to develop a series of orthogonal bacterial ribosomes•mRNA pairs by mutating the
Shine-Delgarno sequence of an mRNA and the corresponding complementary region of
ribosomal RNA [26]. Using this system, orthogonal ribosomal evolution experiments can be
undertaken without disrupting the endogenous cellular translational machinery. Using clever
selection methodology, Neumann et al. evolved ribosomes that more efficiently decode
TAG stop codons as well as four-base frameshift codons [27,28••]. This work is significant
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as one requirement for UAA incorporation is the need for ‘blank’ codons that permit site-
specific incorporation of UAA without disturbing the codon usage of the 20 naturally
occurring amino acids. Neumann et al. have demonstrated the utllity of engineered
ribosomes by efficiently incorporating two different unnatural amino acids into a single
protein in high yield [28••]. In this report, simultaneous incorporation of a cross-reactive
azide-containing amino acid and an alkyne-containing amino acid into a model protein
permitted the formation of a covalent ‘staple’ crosslink between both UAAs using ‘click’
chemistry.
Non-natural Cofactors and Directed Evolution
Novel chemical diversity can also be introduced into proteins through artificial cofactors.
Since early work by Kaiser and Whitesides [29,30], there has been considerable attention
paid to developing artificial cofactors, particularly metallocenters, to generate new activities.
Metalloprotein design is very broad and beyond the scope of this review, but several recent
reviews highlight the multiple achievements in this area [6,31,32]. Of interest for directed
evolution are in vivo or hybrid approaches that allow the new cofactor to be introduced in a
way that leaves the protein amenable to mutagenesis and high-throughput screening. Recent
work suggests that this is not far off, as improved metalloprotein construction together with
rational protein engineering has produced enzymes with high selectivity and multiple
hundreds of turnovers [33,34]. Directed evolution will provide an additional systematic
approach to optimizing these systems.
One approach to making artificial metalloproteins uses biotin-streptavidin technology to
create a hybrid catalyst consisting of the protein and a metal center, as pioneered by
Whitesides [30] and expanded by Reetz, Ward and others [30,32,35]. Non-natural transition
metal complexes attached by chemical linkers to biotin are immobilized within avidin or
streptavidin by exploiting these proteins’ extremely strong affinity (Kd ~ 1014 M−1) for
biotin. The inherent catalytic activity of the transition metal complex in association with the
three-dimensional protein active site provides a platform for stereospecific organometallic
catalysis. Streptavidin is thermostable, and both streptavidin and avidin have known crystal
structures and are amenable to mutagenesis and bacterial expression, making them good
candidates for directed evolution.
Several labs have explored a variety of reactions using this approach, including the
asymmetric Rh-catalyzed hydrogenation of alkenes [34,36], Pd-catalyzed allylic alkylation
[37], Mn-salen-catalyzed asymmetric sulfoxidation [38], and Rh- or Ru-catalyzed transfer
hydrogenation [33,39]. Ward and colleagues have combined chemical optimization of
transition metal-biotin conjugates with site-directed mutagenesis to produce hybrid enzymes
with high conversion and enantioselectivity for various reactions [35,36,37]. A recent report
describes immobilizing one of the four streptavidin monomers to a biotinylated solid
support, which accelerates the production of homogeneous metalloproteins and enables
moderate throughput screening [39]. By saturation mutagenesis of specific residues in the
active site of streptavidin, the authors generated Ru-based transfer hydrogenation catalysts
with up to 98% ee for the reduction of p-methylacetophenone [33]. Reetz and colleagues
have optimized a high-throughput screen for the hydrogenation of α-acetamido-acrylic acid
esters [34]. Iterative saturation mutagenesis of streptavidin and screening produced mutant
biotinylated diphosphine-Rh complex hybrid catalysts with improved enantioselectivity
(both R and S).
Artificial metalloprotein catalysts often require a considerable quantity of purified protein to
exhibit measurable activity [34]. In addition, reactions of new metallocofactors with other
cellular components may negatively affect catalyst stability or generate non-specific reaction
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centers that reduce stereoselectivity. This makes it impossible to screen hundreds of mutant
enzymes, as large-scale expression and purification are required to produce enough
homogeneous protein for examination. In the end, new approaches that permit efficient in
vivo generation of artificial metallocenters may be useful. As a start, Schultz and colleagues
have recently demonstrated the genetic incorporation of a variety of novel unnatural metal-
chelating amino acids [40,41]. It will be interesting to see this technology adapted to
introduce pre-organized transition metal-containing amino acids into proteins in vivo.
Exciting new opportunities for artificial enzyme design and evolution are enabled by new
technology for incorporation of non-natural metalloporphyrins into proteins. Traditional
methods have required harsh in vitro unfolding, stripping and heme reconstitution protocols.
Marletta and colleagues recently demonstrated that an engineered E. coli strain deficient in
heme biosynthesis can take up exogenous artificial metalloporphyrins from defined media
and incorporate them into heme proteins [42]. In a recent report, they introduced Ru(II)-CO
mesoporphyrin IX into myoglobin and the H-NOX (heme nitric oxide/oxygen) binding
protein from Thermoanaerobacter tengcongensis, resulting in fluorescent biosensors for
oxygen [43•]. Lelyveld et al. have recently introduced an alternative method for in vivo non-
natural metalloporphyrin incorporation by exploiting the relaxed substrate specificity of a
naturally occurring bacterial heme transport protein, ChuA. By overexpressing ChuA in
iron-deficient media in the presence of Mn3+-protoporphyrin IX, they produced a
manganese-substituted cytochrome P450 that demonstrated an enhanced metal-induced T1
relaxation of water compared to the native heme protein [44•]. This will significantly
enhance the performance of protein-based, ligand-sensitive MRI contrast sensors made by
directed evolution [45•]. These strategies for the in vivo generation of proteins with novel
porphyrins have opened the door to their modification and optimization by directed
evolution.
Computational Enzyme Design and Directed Evolution
While introducing unnatural amino acids or metallocenters provides a direct means to
establish new chemistry, engineering new enzymatic reactivities using the building blocks
nature has already provided represents one of the ultimate tests of our understanding of
protein structure and function. Recent work from the Baker laboratory has demonstrated the
progress made in computational design of new enzyme catalysts [8•,9,10••]. Unfortunately,
the catalytic activities of these designed enzymes do not come close to the levels exhibited
by natural enzymes. But that may not be true for long. Rational design can provide a starting
point by arranging at least the minimum features for catalysis within an active site; it should
be possible for laboratory evolution to improve upon these rudimentary designs.
A simplified description of the computational design methodology involves several key
steps: (1) using computational algorithms to generate idealized active sites to stabilize an
enzymatic transition state, (2) identifying protein scaffolds from a library of folds that can fit
the desired transition state model (Rosetta Match), (3) optimizing the entire active site
within selected scaffolds, and (4) the synthesis, expression and characterization of a number
of top ranking designs. Using this approach, the Baker lab has designed novel enzymes that
catalyze a variety of reactions including a retro-aldol condensation [9], the Kemp
elimination [10••] and a stereoselective bimolecular Diels-Alder reaction [8•]. These works
demonstrate that measurable non-natural enzyme activity can be engineered within protein
scaffolds. The resulting activity, however, is generally extremely low, with rate
enhancements over the uncatalyzed reaction reaching up to 105 in only the most successful
examples. In some cases, rational mutational analysis has led to small improvements in
activity [8•,9,46•]. For example, during the biochemical evaluation of a computationally
designed retroaldolase, deletion of two hydrogen bonding residues that were believed to be
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key for catalysis surprisingly led to a five-fold increase in enzyme activity [46•]. This work
underscores design failures but also highlights how subsequent improvements can be
achieved through mutation. If enough product is produced by the initial enzyme design to
enable high-throughput screening, directed evolution can be applied to yield further
improvements in activity.
Optimization of novel catalysis by directed evolution has been demonstrated for an enzyme
computationally designed for the Kemp elimination of 5-nitrobenzisoxazole, a model proton
transfer reaction (figure 2a) [10••]. Three elements were designed into the transition state
model to promote catalysis (figure 2a and b): (1) A catalytic base (either a sole Asp/Glu
residue, or a His residue polarized by an Asp or Glu residue (His-Asp dyad) was oriented in
position to deprotonate the oxazole C-H moiety. (2) A hydrogen bond donor (Ser or Lys)
was positioned to stabilize the accumulating negative charge that results on the phenolic
oxygen. (3) An aromatic residue was added to form a favorable π-stacking interaction with
the planar transition state (figure 2b). Of the 59 designs tested, 8 produced active enzymes
with various active site structures. kcat/Kmvalues ranged from ~ 6 to 160 M−1s−1 , with rate
accelerations as much as 105.
The product formed by the Kemp reaction has a unique absorbance spectrum, which can be
used for high-throughput activity-based screening. This allowed the authors to use directed
evolution to screen random mutants for improved activity. Construct Ke07, for which there
was a crystal structure, was chosen as the starting parent. Seven rounds of iterative
mutagenesis (error-prone PCR and DNA shuffling) and screening resulted in a variant with
8 additional mutations, a more than 200-fold improvement in kcat/Km (from ~12 to 2,600
M−1s−1) and a ~100-fold increase in kcat/kuncat (from 104 to 106) (figure 2b and c). Recently
Khersonsky et al. have solved the crystal structures of several intermediates from the
directed evolution process [47••]. From these, they were able to identify several
determinants of the improved activity as well as limitations of the initial design. The crystal
structure of Ke07 showed that the distance between the designed hydrogen bond donor,
Lys222, and the catalytic Glu101 was shorter than anticipated (figure 2b), suggesting that
the interaction of these two residues may prevent deprotonation of the oxazole ring by
Glu101. An Ile7Asp mutation introduced during the 4th round of selection resulted in a salt
bridge to Lys222, drawing it away from Glu101 and possibly allowing both residues to
stabilize the transition state more efficiently (figure 2c). Other mutations have been
associated with tuning the ligand-binding environment, altering the pKa of the catalytic base
and improving its interaction with the substrate [47••].
While the results outlined above can be considered a tremendous success in the de novo
design of enzymatic activity, there are also cautionary lessons. Many natural enzymes
enhance the reaction rate (kcat/kuncat) by more than a factor of 1012 [11,48], whereas the
most successful designed enzymes only boast a106-fold rate enhancement, even after further
optimization by directed evolution. These values are similar to those established by catalytic
antibodies decades earlier. A catalytic antibody for the Kemp elimination developed by
Hilvert and colleagues showed a kcat/Km of 5,500 M−1s−1, eerily similar to the designed
Kemp eliminase (2,600 M−1s−1) [49]. While there is clearly plenty of room for
improvement, seven rounds of directed evolution of the designed Kemp eliminase provided
only a 200-fold increase in kcat/Km; additional rounds of mutagenesis and screening yielded
no further benefit. This, along with myriad failed efforts to used directed evolution to
improve catalytic antibodies, underscores the fact that not all protein designs are evolvable.
The limited improvements observed in designed proteins reflect their local, non-productive
fitness landscapes marked by the lack of nearby fitness peaks (not every bad enzyme is near
a good enzyme) or by local maxima where subsequent mutations are not advantageous
(figure 3) [1]. The goal of course is to find those starting points that lie on large fitness
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peaks, where improvement is not only possible, but easy to access. Mechanistic studies of
designed proteins, updated crystal structures bound to transition state analogues, and
improvements in computational methodology may lead to improvements in designed
enzymes [48]. But, the most important task may well be to learn what makes one enzyme
evolvable and another not.
Conclusions
Engineering novel functions in proteins presents an exciting challenge for protein
engineering. However, efforts to date to generate novel catalysts have primarily
demonstrated that we are getting good at making bad enzymes. Making good enzymes will
require a whole new level of insight, or new methodologies altogether. Technologies such as
those reviewed here can be viewed as creating new starting points where optimization
through evolution might be possible. This is how Nature would approach the problem. Yet,
while directed evolution offers a mechanism for protein optimization through the
accumulation of beneficial mutations, there is no guarantee that the new proteins lie at the
base of a fitness peak [1]. Lessons from these initial successes and failures should stimulate
improvements in design approaches leading to new paths for discovery. Finally, advances in
UAA incorporation in combination with new cloning strategies such as TAG codon
scanning [50] may permit the random introduction of UAAs within a protein sequence. This
way, directed evolution could improve protein fitness using functionality not available to
natural proteins.
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Figure 1.
Directed evolution of novel UAA-dependent binding proteins using phage display [22•,23••,
25•]. (a) General phage display protocol for selection of HIV gp120 specific ScFv proteins.
X – E. coli refers to bacterial strains engineered for the incorporation of UAA into proteins
in response to the TAG stop codon. (b) CDR3 sequences of gp120 specific sulfotyrosine
(sY)-containing antibody, 412d, and new evolved variants are shown. Replacing sY with
natural tyrosine reduces binding of the wild type (412d-YY) and evolved variants. (c)
Structure of sulfotyrosine. (d) Novel reactive groups such as boronic acids can provide
chemical warheads for binding molecules such as hydroxyl-rich sugars.
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Figure 2.
Directed evolution of a computationally designed Kemp eliminase [10••,47••]. (a) Kemp
elimination reaction mechanism (left), transition state (middle), and product (right) are
shown. (b) A schematic of the minimal computationally designed active site of parent Kemp
eliminase Ke07 is shown on the left. In the designed model, the distance between Glu101
and Lys222 is approximately 3.6 Å. The observed distance between these two residues is
significantly shorter, according to the crystal structure (right, PDB: 2RKX). (c) 7 rounds of
directed evolution starting from Ke07 improved catalytic efficiency more than 200 fold. A
crystal structure for a variant from round 4 of evolution (4-1E/11H, PDB 3IIO) is shown on
the right. The interaction between Glu101 and K222 is significantly diminished in this
structure.
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Figure 3.
Developing technologies such as unnatural amino acid (UAA) mutagenesis, non-natural
cofactor engineering and computational design can facilitate the introduction of new
function, distinct from those demonstrated in Nature, within a protein scaffold. Fitness is a
measure of how well protein sequences perform the target function. Most proteins possess
no activity (shown in grey on the fitness landscape). Successful designs (shown as circles)
may show weak initial activities that can be starting points for further optimization by
directed evolution. Directed evolution leading only to small improvements may indicate that
an initial design lies near low fitness peaks (red trajectory) or that further improvements are
limited by the presence of local optima (blue trajectory). An ideal design would yield a
sequence that lies on a large fitness peak (green trajectory), where multiple rounds of
mutagenesis and screening produce a highly functional protein.
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